This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vermes, C.
Right arrow Articles by Glant, T. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vermes, C.
Right arrow Articles by Glant, T. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Facebook   Add to Technorati   Add to Twitter  
What's this?
The Journal of Bone and Joint Surgery 83:201 (2001)
© 2001 The Journal of Bone and Joint Surgery, Inc.

The Effects of Particulate Wear Debris, Cytokines, and Growth Factors on the Functions of MG-63 Osteoblasts

Csaba Vermes, MD, Raman Chandrasekaran, PhD, Joshua J. Jacobs, MD, Jorge O. Galante, MD, DMSc, Kenneth A. Roebuck, PhD and Tibor T. Glant, MD, PhD

Investigation performed at Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois
Csaba Vermes, MD Raman Chandrasekaran, PhD Joshua J. Jacobs, MD Jorge O. Galante, MD, DMSc Tibor T. Glant, MD, PhD Department of Orthopedic Surgery, Rush University, Rush-Presbyterian-St. Luke's Medical Center, 1653 West Congress Parkway, Chicago, IL 60612. E-mail address for T.T. Glant: tglant{at}rush.edu
Kenneth A. Roebuck, PhD Department of Immunology/Microbiology, Rush University, Rush-Presbyterian-St. Luke's Medical Center, 1653 West Congress Parkway, Chicago, IL 60612
Although none of the authors has received or will receive benefits for personal or professional use from a commercial party related directly or indirectly to the subject of this article, benefits have been or will be received but are directed solely to a research fund, foundation, educational institution, or other nonprofit organization with which one or more of the authors is associated. Funds were received in total or partial support of the research or clinical study presented in this article. The funding sources were the National Institutes of Health, Zimmer, and the Musculoskeletal Research Foundation.

Background: Particle-challenged cells release cytokines, chemokines, and eicosanoids, which contribute to periprosthetic osteolysis. The particle-induced activation of macrophages and monocytes has been extensively studied, but only limited information is available on the response of osteoblasts to particulate wear debris. This study examines the effects of particulate wear debris, proinflammatory cytokines, and growth factors on osteoblast functions.

Methods: MG-63 osteoblasts were treated with metal particles (titanium, titanium alloy, and chromium orthophosphate) or polymeric particles (polyethylene and polystyrene) of phagocytosable sizes or were treated with exogenous cytokines and growth factors. The kinetics of particle phagocytosis and the number of engulfed particles were assessed with use of fluoresceinated particles. Cell proliferation was determined according to [3H]-thymidine incorporation, and cell viability was determined by either fluorescein diacetate uptake or trypan blue exclusion. Expressions of osteoblast-specific genes were quantified with Northern blot hybridization, and the secretions of osteoblast-specific proteins and cytokines were analyzed by enzyme-linked immunosorbent assays.

Results: MG-63 osteoblasts phagocytosed particles and became saturated after twenty-four hours. A maximum of forty to sixty particles per cell were phagocytosed. Each type of particle significantly suppressed procollagen a1[I] gene expression (p < 0.05), whereas other osteoblast-specific genes (osteonectin, osteocalcin, and alkaline phosphatase) did not show significant changes. Particle-stimulated osteoblasts released interleukin-6 (p < 0.05) and a smaller amount of transforming growth factor-b1. Particles reduced cell proliferation in a dose-dependent manner without affecting cell viability (p < 0.05). Exogenous tumor necrosis factor-a also enhanced the release of interleukin-6 (p < 0.01) and transforming growth factor-b1 (p < 0.05), whereas the secretion of transforming growth factor-b1 was increased by insulin-like growth factor-I and prostaglandin E2 as well. Insulin-like growth factor-I and transforming growth factor-b1 significantly increased procollagen a1[I] gene expression in osteoblasts (p < 0.05), while tumor necrosis factor-a and prostaglandin E2 significantly suppressed procollagen a1[I] gene expression (p < 0.01). In contrast, neither exogenous nor endogenous interleukin-6 had any effect on other cytokine secretion, on proliferation, or on procollagen a1[I] gene expression. The transcription inhibitor actinomycin D reduced both procollagen a1[I] transcription and interleukin-6 production. Inhibitors of protein synthesis (cyclohexamide) and intracellular protein transport (brefeldin A and monensin) blocked the release of interleukin-6, but none of these compounds influenced the suppressive effect of titanium on procollagen a1[I] gene expression.

Conclusions: MG-63 osteoblasts phagocytose particulate wear debris, and this process induces interleukin-6 production and suppresses type-I collagen synthesis. Osteoblast-derived interleukin-6 may induce osteoclast differentiation and/or activation, but the resorbed bone cannot be replaced by new bone because of diminished osteoblast function (reduced type-I collagen synthesis). Exogenous cytokines (tumor necrosis factor-a and interleukin-1b), growth factors (insulin-like growth factor-I and transforming growth factor-b1), and prostaglandin E2 can modify particulate-induced alterations of osteoblast functions.

Clinical Relevance: Altered osteoblast functions probably contribute to the progression of periprosthetic osteolysis. Suppressed osteoblast functions, however, could be compensated for by certain growth factors, such as insulin-like growth factor-I or transforming growth factor-b1. These growth factors, if delivered locally, may have therapeutic potential to prevent or reverse periprosthetic osteolysis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Facebook Facebook   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 JBJSHome page
F. A. Matsen III, J. Clinton, J. Lynch, A. Bertelsen, and M. L. Richardson
Glenoid Component Failure in Total Shoulder Arthroplasty
J. Bone Joint Surg. Am., April 1, 2008; 90(4): 885 - 896.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
D. S. Rakshit, K. Ly, T. K. Sengupta, B. J. Nestor, T. P. Sculco, L. B. Ivashkiv, and P. E. Purdue
Wear Debris Inhibition of Anti-Osteoclastogenic Signaling by Interleukin-6 and Interferon-{gamma} Mechanistic Insights and Implications for Periprosthetic Osteolysis
J. Bone Joint Surg. Am., April 1, 2006; 88(4): 788 - 799.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
R. Kang and P. J. Stern
Humeral Nonunion Associated with Metallosis Secondary to Use of a Titanium Flexible Humeral Intramedullary Nail: A Case Report
J. Bone Joint Surg. Am., December 9, 2002; 84(12): 2266 - 2269.
[Full Text] [PDF]

Home page
 JBJSHome page
M. H. Huo and S. M. Cook
What's New in Hip Arthroplasty
J. Bone Joint Surg. Am., October 1, 2001; 83(10): 1598 - 1610.
[Full Text] [PDF]